The Latest in Melanoma

BRAF Inhibitor Cuts Death Risk in Advanced Melanoma

June 5, 2011

Melanoma

BRAF Inhibitor Cuts Death Risk in Advanced Melanoma

June 5, 2011

Melanoma

DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis

June 3, 2011

Melanoma

Ipilimumab and Beyond: New Therapies Imminent in Melanoma

May 11, 2011

Melanoma

Lymphatic Invasion Predicts Recurrence in Merkel Cell Cancer

April 19, 2011

FDA Approves Peginterferon Alfa-2b for Melanoma

April 13, 2011

Melanoma

Thin vs. Thick Melanomas: Both Carry Same SLN Involvement Risk

April 10, 2011

Melanoma

Once Again, Results Mixed for SN Biopsy in Melanoma

April 5, 2011

Melanoma

FDA: Ipilimumab Approved for Metastatic Melanoma

March 25, 2011

Melanoma

Serum Antibody Profiling in Melanoma

March 22, 2011

Melanoma

FDA Okay Expected Soon for Melanoma Drug Ipilimumab

March 16, 2011

Melanoma

Preop Ultrasound Unreliable in Melanoma Staging

March 16, 2011

Melanoma

Ipilimumab for Metastatic Melanoma

March 16, 2011

Melanoma

Capecitabine May Protect Against Skin Cancers After Transplant

March 15, 2011

Capecitabine to Prevent Squamous Cell Carcinoma

March 15, 2011

Melanoma